These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6397356)

  • 21. Flecainide: a new prototype antiarrhythmic agent.
    Nappi JM; Anderson JL
    Pharmacotherapy; 1985; 5(4):209-21. PubMed ID: 3898035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conversion of supraventricular arrhythmias to sinus rhythm using flecainide.
    Goy JJ; Grbic M; Hurni M; Finci L; Maendly R; Duc J; Sigwart U
    Eur Heart J; 1985 Jun; 6(6):518-24. PubMed ID: 4043101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flecainide: a new antiarrhythmic agent].
    Leclercq JF; Coumel P
    Arch Mal Coeur Vaiss; 1983 Oct; 76(10):1218-30. PubMed ID: 6418100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
    Hodges M; Haugland JM; Granrud G; Conard GJ; Asinger RW; Mikell FL; Krejci J
    Circulation; 1982 May; 65(5):879-85. PubMed ID: 7074749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of flecainide in the therapy of chronic ventricular arrhythmia using the acute oral load method].
    Schwartz PJ; Facchini M; Bonazzi O; Cuspidi C; Priori S; Varisco T; Zuanetti G
    G Ital Cardiol; 1985 Mar; 15(3):273-82. PubMed ID: 4018465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiarrhythmic therapy with flecainide in combination and comparison with propranolol.
    Stern H; Scheininger M; Theisen F; Theisen K
    Drugs; 1985; 29 Suppl 4():77-85. PubMed ID: 4006784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of intravenous pirmenol hydrochloride for treatment of ventricular arrhythmias: a controlled comparison with lidocaine.
    Anderson JL; Lutz JR; Sanders SW; Nappi JM
    J Cardiovasc Pharmacol; 1983; 5(2):213-20. PubMed ID: 6188892
    [No Abstract]   [Full Text] [Related]  

  • 28. [Electrophysiological effects of the new antiarrhythmic drug flecainide (R 818) in man (author's transl)].
    Seipel L; Abendroth RR; Breithardt G
    Z Kardiol; 1981 Jul; 70(7):524-9. PubMed ID: 7269731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of flecainide in the management of ventricular arrhythmias: comparative study with amiodarone.
    Dubner SJ; Elencwajg BD; Palma S; Mendelzon R; Ramos A; Bertolasi CA
    Am Heart J; 1985 Mar; 109(3 Pt 1):523-8. PubMed ID: 3883728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flecainide dose-response relations in stable ventricular arrhythmias.
    Woosley RL; Siddoway LA; Duff HJ; Roden DM
    Am J Cardiol; 1984 Feb; 53(5):59B-65B. PubMed ID: 6695819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of flecainide on chronic ventricular arrhythmias (author's transl)].
    Bluschke V; Breithardt G; Abendroth RR; Seipel L
    Z Kardiol; 1982 Apr; 71(4):284-8. PubMed ID: 6178228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The proarrhythmic effects of flecainide.
    Nathan AW; Hellestrand KJ; Bexton RS; Spurrell RA; Camm AJ
    Drugs; 1985; 29 Suppl 4():45-53. PubMed ID: 4006779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flecainide: steady state electrophysiologic effects in patients with remote myocardial infarction and inducible sustained ventricular arrhythmia.
    Webb CR; Morganroth J; Senior S; Spielman SR; Greenspan AM; Horowitz LN
    J Am Coll Cardiol; 1986 Jul; 8(1):214-20. PubMed ID: 3711519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of intravenous flecainide on atrial vulnerability in man.
    Pop T; Treese N
    Drugs; 1985; 29 Suppl 4():1-6. PubMed ID: 4006774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemodynamic and antiarrhythmic effects of intravenous flecainide acetate in chronic congestive heart failure.
    Dunselman PH; Kingma JH; van Wijk LM; Dijk A; Wesseling H; Lie KI
    Drugs; 1985; 29 Suppl 4():58-64. PubMed ID: 4006780
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.
    Duff HJ; Roden DM; Maffucci RJ; Vesper BS; Conard GJ; Higgins SB; Oates JA; Smith RF; Woosley RL
    Am J Cardiol; 1981 Dec; 48(6):1133-40. PubMed ID: 7304461
    [No Abstract]   [Full Text] [Related]  

  • 37. Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
    Holmes B; Heel RC
    Drugs; 1985 Jan; 29(1):1-33. PubMed ID: 3882390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of intravenous and oral flecainide on ventricular tachycardia.
    Ward DE; Cheesman M; Dancy M
    Int J Cardiol; 1986 Mar; 10(3):251-62. PubMed ID: 3957470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy, safety, and pharmacokinetics of a concentration-maintaining regimen of intravenous pirmenol.
    Reiter MJ; Hammill SC; Shand DG; Verghese C; McCarthy E; Pritchett EL
    Am J Cardiol; 1983 Jul; 52(1):83-7. PubMed ID: 6858934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of the antiarrhythmic agent flecainide acetate on acute and chronic pacing thresholds.
    Hellestrand KJ; Burnett PJ; Milne JR; Bexton RS; Nathan AW; Camm AJ
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):892-9. PubMed ID: 6195608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.